There is considerable interest in innovative dialysis therapies for people with kidney failure, in particular to remove larger circulating toxins that are poorly removed by standard haemodialysis, which are associated with higher mortality and infection.

In an updated Cochrane review, published in May 2015, Suetonia Palmer from Christchurch in New Zealand and colleagues, brought together the studies of the impact of haemodiafiltration on patient outcomes. She tells us what they found in this evidence pod.

Listen to this podcast: Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease